Sage Growth Partners (Sage), a national healthcare growth strategy and marketing firm, has released a new research report, The Medicaid Maternity Cliff. The report reveals a looming crisis in maternal healthcare, as more than half of pregnant women on Medicaid anticipate losing coverage due to eligibility redeterminations.
What You Should Know
Sage Growth Partners has released its Q1 2026 report, âThe Medicaid Maternity Cliff,â identifying a looming crisis in maternal and infant healthcare access.52% of Medicaid-enrolled mothers expect to lose their coverage due to eligibility redeterminations, while 84% of health plan leaders anticipate moderate to severe care disruption.The report identifies significant clinical risks, with 72% of leaders citing delayed or avoided prenatal and postpartum care as a primary concern.Vulnerable populationsâincluding rural families, postpartum mothers beyond 60 days, and NICU familiesâare expected to be disproportionately impacted by coverage churn.In response, 68% of health plan leaders are increasing member education and outreach efforts to mitigate the âemotional and behavioralâ impact of potential loss.
For the millions of women relying on Medicaid for maternal care, the administrative process of eligibility redetermination is increasingly becoming a clinical hurdle. According to the first report in Sage Growth Partnersâ State of Maternal & NICU Care 2026 series, the U.S. is facing a âMedicaid Maternity Cliff.â As federal policy changes increase the frequency of eligibility reviews, more than half of pregnant and recently pregnant women on Medicaid anticipate losing their healthcare access mid-journey, threatening the continuity of care required for safe maternal and infant outcomes.
The findings underscore that this is not merely an administrative issue but a public health crisis in the making. When coverage disappears, the established relationship between a mother and her care team often dissolves, leading to fragmented care and increased financial barriers that can have lasting consequences for both mother and child.
Clinical Consequences of the âCoverage Cliffâ
The survey of 50 health plan leaders and 300 mothers reveals a stark alignment between member fear and executive concern. Health plan leaders are sounding the alarm on the downstream effects of coverage loss, specifically:
72% cite delayed or avoided prenatal and postpartum care.66% point to breakdowns in care continuity.64% anticipate increased financial barriers for families.
Dan DâOrazio, CEO of Sage Growth Partners, notes that âwhen coverage disappears mid-journey, so does continuity.â This gap is particularly dangerous for high-risk populations, such as those in rural areas with limited provider options or families navigating the complexities of the NICU, where any interruption in care management can be catastrophic.
Health Plan Response: Bridging the Gap
Despite the significant scale of the challengeâwith 80% of leaders expecting at least 10% of their members to lose coverageâhealth plans are proactively moving to stabilize their populations. Nearly seven in 10 plans are increasing outreach and member education to help navigate the âfear and uncertaintyâ driving member concern.
Beyond education, plans are strengthening partnerships with local providers and community organizations to ensure that even if a memberâs status changes, they remain connected to essential services. DâOrazio emphasizes that proactive outreach and smarter care management will be the critical âsafety netsâ needed to keep members from falling off the cliff.
Why This Matters
The âMaternal Cliffâ is a warning shot for the healthcare industryâs push toward health equity. If 52% of the most vulnerable mothers in the system are âon the edge of the precipice,â the gains made in maternal mortality and infant health over the last decade are at risk of being erased.
It is far more expensive to manage a late-stage complication resulting from avoided care than it is to invest in the âsmarter care managementâ Sage recommends. In 2026, the successful health plan wonât just process redeterminations; they will treat coverage stability as a core clinical metric.
